Article info

PDF

Inflammation bowel disease I
Cost analysis of screening according to ECCO guidelines for prevention of opportunistic infections in infliximab-treated ibd patients

Citation

Metz A, Elliott T, Hull B, et al
Cost analysis of screening according to ECCO guidelines for prevention of opportunistic infections in infliximab-treated ibd patients

Publication history

  • First published March 13, 2011.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.